|
Atomistry » Iron » PDB 4g39-4gl5 » 4gl5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Iron » PDB 4g39-4gl5 » 4gl5 » |
Iron in PDB 4gl5: Structure of Human Placental Aromatase Complexed with Designed Inhibitor HDDG029 (Compound 4)Enzymatic activity of Structure of Human Placental Aromatase Complexed with Designed Inhibitor HDDG029 (Compound 4)
All present enzymatic activity of Structure of Human Placental Aromatase Complexed with Designed Inhibitor HDDG029 (Compound 4):
1.14.14.1; Protein crystallography data
The structure of Structure of Human Placental Aromatase Complexed with Designed Inhibitor HDDG029 (Compound 4), PDB code: 4gl5
was solved by
D.Ghosh,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Iron Binding Sites:
The binding sites of Iron atom in the Structure of Human Placental Aromatase Complexed with Designed Inhibitor HDDG029 (Compound 4)
(pdb code 4gl5). This binding sites where shown within
5.0 Angstroms radius around Iron atom.
In total only one binding site of Iron was determined in the Structure of Human Placental Aromatase Complexed with Designed Inhibitor HDDG029 (Compound 4), PDB code: 4gl5: Iron binding site 1 out of 1 in 4gl5Go back to![]() ![]()
Iron binding site 1 out
of 1 in the Structure of Human Placental Aromatase Complexed with Designed Inhibitor HDDG029 (Compound 4)
![]() Mono view ![]() Stereo pair view
Reference:
D.Ghosh,
J.Lo,
D.Morton,
D.Valette,
J.Xi,
J.Griswold,
S.Hubbell,
C.Egbuta,
W.Jiang,
J.An,
H.M.Davies.
Novel Aromatase Inhibitors By Structure-Guided Design. J.Med.Chem. V. 55 8464 2012.
Page generated: Mon Aug 5 02:45:44 2024
ISSN: ISSN 0022-2623 PubMed: 22951074 DOI: 10.1021/JM300930N |
Last articlesZn in 9MJ5Zn in 9HNW Zn in 9G0L Zn in 9FNE Zn in 9DZN Zn in 9E0I Zn in 9D32 Zn in 9DAK Zn in 8ZXC Zn in 8ZUF |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |